11-4769643-CG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001004752.2(OR51F1):βc.295delβ(p.Arg99ValfsTer41) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,603,756 control chromosomes in the GnomAD database, including 49,713 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.28 ( 6945 hom., cov: 20)
Exomes π: 0.23 ( 42768 hom. )
Consequence
OR51F1
NM_001004752.2 frameshift
NM_001004752.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.839
Genes affected
OR51F1 (HGNC:15196): (olfactory receptor family 51 subfamily F member 1) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. This olfactory receptor gene is a segregating pseudogene, where some individuals have an allele that encodes a functional olfactory receptor, while other individuals have an allele encoding a protein that is predicted to be non-functional. [provided by RefSeq, Jun 2015]
MMP26 (HGNC:14249): (matrix metallopeptidase 26) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 11-4769643-CG-C is Benign according to our data. Variant chr11-4769643-CG-C is described in ClinVar as [Benign]. Clinvar id is 403275.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR51F1 | NM_001004752.2 | c.295del | p.Arg99ValfsTer41 | frameshift_variant | 1/1 | ENST00000624103.2 | |
MMP26 | NM_021801.5 | c.-145+2303del | intron_variant | ENST00000380390.6 | |||
MMP26 | NM_001384608.1 | c.-153+2303del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR51F1 | ENST00000624103.2 | c.295del | p.Arg99ValfsTer41 | frameshift_variant | 1/1 | NM_001004752.2 | P1 | ||
MMP26 | ENST00000380390.6 | c.-145+2303del | intron_variant | 5 | NM_021801.5 | P1 | |||
MMP26 | ENST00000300762.2 | c.-153+2303del | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.280 AC: 42465AN: 151834Hom.: 6933 Cov.: 20
GnomAD3 genomes
AF:
AC:
42465
AN:
151834
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.207 AC: 51645AN: 249938Hom.: 6810 AF XY: 0.203 AC XY: 27478AN XY: 135060
GnomAD3 exomes
AF:
AC:
51645
AN:
249938
Hom.:
AF XY:
AC XY:
27478
AN XY:
135060
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.230 AC: 333584AN: 1451804Hom.: 42768 Cov.: 27 AF XY: 0.226 AC XY: 163425AN XY: 722640
GnomAD4 exome
AF:
AC:
333584
AN:
1451804
Hom.:
Cov.:
27
AF XY:
AC XY:
163425
AN XY:
722640
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.280 AC: 42524AN: 151952Hom.: 6945 Cov.: 20 AF XY: 0.269 AC XY: 19971AN XY: 74292
GnomAD4 genome
AF:
AC:
42524
AN:
151952
Hom.:
Cov.:
20
AF XY:
AC XY:
19971
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
266
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 4000/12518=31.95% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at